NL-OMON24348Other不适用
Cardiovascular disease in ANCA-associated vasculitis
orthwest Academy0 个研究点目标入组 210 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- Other
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •ANCA-associated vasculitis in accordance with the CHCC guidelines
- •- Over 18 years
排除标准
- •- Pregnancy
研究者
相似试验
进行中（未招募）
不适用
SE OF ABATACEPT IN ANCA-ASSOCIATED VASCULITIS - ABAVASEUCTR2008-004138-26-ITAZIENDA OSPEDALIERA DI PARMA112
已完成
不适用
ANCA associated vasculitis is a relapsing disease; the role of regulatory B cellsautoimmune vessel wall inflammation1000381610047066vasculitisNL-OMON37886niversitair Medisch Centrum Groningen160
已完成
不适用
ANCA-associated Vasculitis and the Metabolic Syndrommetabool syndroomANCA-associated vasculitis (inflammation of the vessel wall caused by the own immune system) and Metabolic syndrome (combination of risk factors that can lead to diseases that involve the heart or blood vessels)1000381610047066NL-OMON34587Medisch Universitair Ziekenhuis Maastricht200
招募中
不适用
Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T CellsANCA Associated VasculitisLupus NephritisNCT06277427Lingli Dong24
进行中（未招募）
不适用
Abatacept in ANCA associated vasculitis: ABAVAS - ABAVASAnti-neutrophil cytoplasmic antibody (ANCA) associated vasculitisMedDRA version: 8.1Level: LLTClassification code 10050894Term: Anti-neutrophil cytoplasmic antibody positive vasculitisEUCTR2006-001859-35-DEImperial College London112